Technical Analysis for PRGO - Perrigo Company

Grade Last Price % Change Price Change
D 30.01 -1.19% -0.36
PRGO closed down 1.19 percent on Monday, March 18, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Calm After Storm Range Contraction -1.19%
Multiple of Ten Bullish Other -1.19%
Weak + Overbought Other -1.19%
Wide Bands Range Expansion -1.19%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 12 hours ago
Possible Inside Day about 12 hours ago
Down 1% about 14 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
2x Volume Pace 4 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Perrigo Company Description

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) primarily in the United States, Israel, the United Kingdom, Mexico, and Australia. The company operates in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, feminine hygiene, diabetes care, and dermatological care, as well as in the areas of animal health category. The Nutritionals segment develops, manufactures, markets, and distributes store brand infant and toddler formula products, infant and toddler foods, vitamins, mineral and dietary supplement products, and oral electrolyte solution products. The Rx Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, and oral liquids and oral solid dosage forms. The API segment develops, manufactures, and markets API used by the generic drug industry and branded pharmaceutical companies. The company sells its products to drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. Perrigo Company was founded in 1887 and is headquartered in Allegan, Michigan.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Diabetes Pharmaceutical Products Gastrointestinal Hygiene Vitamins Dietary Supplement Animal Health Allergy Shampoo Suspension Hormones Prescription Drugs Active Pharmaceutical Ingredients Analgesics Lotion Smoking Nutritional Products Sinus Cough Smoking Cessation Feminine Hygiene Ointments Generic Drug Diabetes Care Pharmaceuticals Segment Perrigo Toddler Food

Is PRGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.225
52 Week Low 25.5168
Average Volume 2,100,731
200-Day Moving Average 31.82
50-Day Moving Average 31.21
20-Day Moving Average 29.41
10-Day Moving Average 29.82
Average True Range 0.98
RSI (14) 49.49
ADX 19.73
+DI 25.89
-DI 25.15
Chandelier Exit (Long, 3 ATRs) 29.25
Chandelier Exit (Short, 3 ATRs) 28.45
Upper Bollinger Bands 33.81
Lower Bollinger Band 25.01
Percent B (%b) 0.57
BandWidth 29.92
MACD Line -0.16
MACD Signal Line -0.51
MACD Histogram 0.3428
Fundamentals Value
Market Cap 4.07 Billion
Num Shares 136 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 375.13
Price-to-Sales 0.93
Price-to-Book 0.91
PEG Ratio 0.83
Dividend 1.08
Dividend Yield 3.60%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.82
Resistance 3 (R3) 30.90 30.70 30.69
Resistance 2 (R2) 30.70 30.50 30.67 30.64
Resistance 1 (R1) 30.36 30.37 30.26 30.28 30.59
Pivot Point 30.16 30.16 30.12 30.13 30.16
Support 1 (S1) 29.82 29.96 29.72 29.74 29.43
Support 2 (S2) 29.62 29.83 29.59 29.38
Support 3 (S3) 29.28 29.62 29.34
Support 4 (S4) 29.20